Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial.
Walline JJ, Walker MK, Mutti DO, Jones-Jordan LA, Sinnott LT, Giannoni AG, Bickle KM, Schulle KL, Nixon A, Pierce GE, Berntsen DA; BLINK Study Group.
JAMA. 2020 Aug 11;324(6):571-580. doi: 10.1001/jama.2020.10834.
Macular function in patients with medium myopia.
Grudzińska EM, Lubiński W, Modrzejewska M.
Doc Ophthalmol. 2023 Apr;146(2):113-120. doi: 10.1007/s10633-022-09907-6. Epub 2022 Dec 4.
Optical interventions for myopia control.
Logan NS, Bullimore MA.
Eye (Lond). 2024 Feb;38(3):455-463. doi: 10.1038/s41433-023-02723-5. Epub 2023 Sep 22.
Myopia Control: Are We Ready for an Evidence Based Approach?
Eppenberger LS, Grzybowski A, Schmetterer L, Ang M.
Ophthalmol Ther. 2024 Jun;13(6):1453-1477. doi: 10.1007/s40123-024-00951-w. Epub 2024 May 7.
[Relationship between Myopia and Light Exposure].
Zhu QR, Liu LQ.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 Nov;52(6):901-906. doi: 10.12182/20211160205.
Interventions for myopia control in children: a living systematic review and network meta-analysis.
Lawrenson JG, Huntjens B, Virgili G, Ng S, Dhakal R, Downie LE, Verkicharla PK, Kernohan A, Li T, Walline JJ.
Cochrane Database Syst Rev. 2025 Feb 13;2(2):CD014758. doi: 10.1002/14651858.CD014758.pub3.
[Myopia and glaucoma].
Faschinger C, Mossböck G.
Wien Med Wochenschr. 2007;157(7-8):173-7. doi: 10.1007/s10354-007-0380-3.
Atropine: Updates on myopia pharmacotherapy.
Shahsuvaryan ML.
Taiwan J Ophthalmol. 2022 Aug 25;14(2):225-229. doi: 10.4103/tjo.TJO-D-22-00060. eCollection 2024 Apr-Jun.
Electrophysiological study of myopia.
Kader MA.
Saudi J Ophthalmol. 2012 Jan;26(1):91-9. doi: 10.1016/j.sjopt.2011.08.002. Epub 2011 Aug 16.
Will treating progressive myopia overwhelm the eye care workforce? A workforce modelling study.
Lingham G, Loughman J, Kuzmenko S, Biba M, Flitcroft DI.
Ophthalmic Physiol Opt. 2022 Sep;42(5):1092-1102. doi: 10.1111/opo.13019. Epub 2022 Jun 21.
